In Canada, as well as globally, chronic pulmonary disease (COPD) is a leading cause of morbidity and mortality. The disease—which causes inflammation of the lungs and makes it more difficult to breathe—is life-changing for patients and their families. In more severe cases, trips to the emergency room and regular hospital admissions are all too frequent, putting a great deal of strain on patients, families and the health care system.
News
Rachel Baker is Professor of Health Economics and Director of the Yunus Centre for Social Business and Health at Glasgow Caledonian University. Before moving to Glasgow in 2010, she worked at the University of Newcastle where she completed her PhD funded by the Medical Research Council (MRC) and her Postdoctoral Fellowship funded by the Economic and Social Research Council (ESRC).
Cragg A, Hau JP, Woo SA, Liu C, Doyle-Waters MM, Hohl CM. Risk factors for addiction among patients receiving prescribed opioids: a systematic review protocol. Syst Rev. 2017 Dec 28;6(1):265.
Tseng OL, Spinelli JJ, Gotay CC, Ho WY, McBride ML, Dawes MG. Aromatase inhibitors are associated with a higher fracture risk than tamoxifen: a systematic review and meta-analysis. Ther Adv Musculoskelet Dis. 2018 Apr;10(4) 71–90.
Abstract
Background: In this paper, our aim was to systematically evaluate published evidence of bone fracture risk associated with tamoxifen and aromatase inhibitors in women aged 65 and under, and diagnosed with nonmetastatic breast cancer.
C2E2 Scientist Corinne Hohl was awarded a UBC Killam Research Fellowship to study medication safety in Nepal, one of the poorest countries in the world where the healthcare available to most is inadequate.
Johnson KM, Bryan S, Ghanbarian S, Sin DD, Sadatsafavi M. Characterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respiratory Research. 2018;19:26. doi.org/10.1186/s12931-018-0731-1
Background
BC has the highest rate of caesarean births in Canada. Here, 34 per cent of babies are delivered by C-section versus the national average of 28 per cent. To put those percentages in context, the World Health Organization says an ideal C-section rate is between 10 and 15 per cent. When it comes to repeat C-sections, BC rates are also very high, and rising, even though vaginal birth after C-section (VBAC) is considered safer for both mom and baby in low-risk pregnancies.
